Crohn's disease-induced non-alcoholic fatty liver disease (NAFLD) sensitizes for severe acute hepatitis B infection and liver failure

被引:12
|
作者
Canbay, A [1 ]
Bechmann, LP [1 ]
Best, J [1 ]
Jochum, C [1 ]
Treichel, U [1 ]
Gerken, G [1 ]
机构
[1] Univ Hosp Essen, Div Gastroenterol & Hepatol, Essen, Germany
来源
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2006年 / 44卷 / 03期
关键词
NASH; NAFLD; IBD; liver failure; Crohn's disease;
D O I
10.1055/s-2006-926502
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Non-alcoholic fatty liver disease (NAFLD) commonly is associated with chronic inflammatory bowel disease (CIBD) and usually is considered to be stable and benign. However, NAFLD - and in particular its subset, non-alcoholic steatohepatitis (NASH) - may lead to progressive liver disease. Moreover, NAFLD sensitizes the liver to injury and increases the risk of developing acute-on-chronic liver failure following a "third hit". We here present one patient with NASH, as probably induced by long-standing Crohn's disease in the absence of ethanol consumption or abuse. The patient acquired an acute HBV infection and died from complications. As based on the clinical and histological findings, Crohn's disease appears to be a risk factor for developing NAFLD and thus to contribute to the progression into NASH. In conclusion, we suggest that Crohn's disease-related NAFLD may increase the vulnerability of the liver, which indicates that patients with a known history of CIBD merit special attention.
引用
收藏
页码:245 / 248
页数:4
相关论文
共 50 条
  • [41] Non-alcoholic fatty liver disease: An emerging liver disease in Taiwan
    Hsu, Ching-Sheng
    Kao, Jia-Horng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2012, 111 (10) : 527 - 535
  • [42] High incidence of non-alcoholic fatty liver disease in patients with Crohn's disease but not ulcerative colitis
    Li, Dejian
    Lu, Chao
    Yu, Chaohui
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (10): : 10633 - 10639
  • [43] Burden and Predictors of Non-Alcoholic Fatty Liver Disease in a Retrospective Cohort of Patients With Crohn's Disease
    Abomhya, Ahmed
    Mahmoodurrahman, Mohammed
    Ayaz, Salman
    Hamad, Hossam
    Khan, Farrah
    GASTROENTEROLOGY RESEARCH, 2022, 15 (02) : 82 - 90
  • [44] The Importance of the Fatty Acid Transporter L-Carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD)
    Savic, Dragana
    Hodson, Leanne
    Neubauer, Stefan
    Pavlides, Michael
    NUTRIENTS, 2020, 12 (08) : 1 - 17
  • [45] Metabolic drivers of non-alcoholic fatty liver disease
    Bence, Kendra K.
    Birnbaum, Morris J.
    MOLECULAR METABOLISM, 2020, 50
  • [46] The fecal mycobiome in non-alcoholic fatty liver disease
    Demir, Munevver
    Lang, Sonja
    Hartmann, Phillipp
    Duan, Yi
    Martin, Anna
    Miyamoto, Yukiko
    Bondareva, Marina
    Zhang, Xinlian
    Wang, Yanhan
    Kasper, Philipp
    Bang, Corinna
    Roderburg, Christoph
    Tacke, Frank
    Steffen, Hans-Michael
    Goeser, Tobias
    Kruglov, Andrey
    Eckmann, Lars
    Starkel, Peter
    Fouts, Derrick E.
    Schnabl, Bernd
    JOURNAL OF HEPATOLOGY, 2022, 76 (04) : 788 - 799
  • [47] Non-alcoholic Fatty Liver Disease and Diabetes Mellitus
    Khneizer, Gebran
    Rizvi, Syed
    Gawrieh, Samer
    DIABETES: FROM RESEARCH TO CLINICAL PRACTICE, VOL 4, 2021, 1307 : 417 - 440
  • [48] Treatment regimens for non-alcoholic fatty liver disease
    Lam, Brian P.
    Younossi, Zobair M.
    ANNALS OF HEPATOLOGY, 2009, 8 : S51 - S59
  • [49] A Comprehensive Review on Non-Alcoholic Fatty Liver Disease
    Sahu, Prerna
    Chhabra, Pratyaksh
    Mehendale, Ashok M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [50] Roles of Ceramides in Non-Alcoholic Fatty Liver Disease
    Hajduch, Eric
    Lachkar, Floriane
    Ferre, Pascal
    Foufelle, Fabienne
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (04) : 1 - 19